EUVIMEDEUVIMED entdecken
Crossref

Early‐Responsive Immunoregulation Therapy Improved Microenvironment for Bone Regeneration Via Engineered Extracellular Vesicles

Tingwei Lu iD, Yuanqi Liu iD, Xiangru Huang iD, Siyuan Sun, Hongyuan Xu, Anting Jin, Xinyu Wang, Xin Gao, Jingyi Liu, Yanfei Zhu, Qinggang Dai, Chao Wang und 2 weitere

Advanced Healthcare Materials · 2024-04 · 13 (11)

DOI: 10.1002/adhm.202303681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 13.12.2023. Verfasst von Tingwei Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center of Craniofacial Orthodontics, Department of Oral and Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong Univer…. Hauptthemen laut MEDLINE: Bone Regeneration, Extracellular Vesicles, Macrophages. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Natural Science Foundation of China, Natural Science Foundation of Shanghai, Clinical Research Plan of SHDC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overactivated inflammatory reactions hinder the bone regeneration process. Timely transformation of microenvironment from pro‐inflammatory to anti‐inflammatory after acute immune response is favorable for osteogenesis. Macrophages play an important role in the immune response to inflammation. Therefore, this study adopts TIM3 high expression extracellular vesicles (EVs) with immunosuppressive function to reshape the early immune microenvironment of bone injury, mainly by targeting macrophages. These EVs can be phagocytosed by macrophages, thereby increasing the infiltration of TIM3‐positive macrophages (TIM3 + macrophages) and M2 subtypes. The TIM3 + macrophage group has some characteristics of M2 macrophages and secretes cytokines, such as IL‐10 and TGF‐β1 to regulate inflammation. TIM3, which is highly expressed in the engineered EVs, mediates the release of anti‐inflammatory cytokines by inhibiting the p38/MAPK pathway and promotes osseointegration by activating the Bmp2 promoter to enhance macrophage BMP2 secretion. After evenly loading the engineered EVs into the hydrogel, the continuous and slow release of EVs TIM3OE recruits more anti‐inflammatory macrophages during the early stages of bone defect repair, regulating the immune microenvironment and eliminating the adverse effects of excessive inflammation. In summary, this study provides a new strategy for the treatment of refractory wounds through early inflammation control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone RegenerationExtracellular VesiclesMacrophagesAnimalsMiceRAW 264.7 CellsOsteogenesisCytokinesMaleCellular MicroenvironmentMice, Inbred C57BL

Stichwörter der Autor:innen

TIM3 proteinbone regenerationextracellular vesiclesimmunoregulationmacrophages

Substanzen

Cytokines

Autor:innen und Institutionen

  • Center of Craniofacial Orthodontics, Department of Oral and Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong Un…
  • The 2nd Dental Center, Ninth People's Hospital, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology,…
  • Department of Obstetrics & Gynecology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.

ORCID-Profile: Tingwei Lu, Yuanqi Liu, Xiangru Huang, Lingyong Jiang

Förderung

  • Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Clinical Research Plan of SHDC
  • Research Discipline Fund from Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, and College of Stomatology, Shanghai Jiao Tong Univers…
  • the Biomaterials and Regenerative Medicine Institute Cooperative Research Project Shanghai Jiao Tong University School of Medicine
  • Two-Hundred Talent Project of Shanghai Jiao Tong University School
  • Shanghai Science and Technology Innovation Action Plan-International Science and Technology Cooperation Program
  • Original Exploration Project of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Lu, T., Liu, Y., Huang, X., Sun, S., Xu, H., Jin, A., Wang, X., Gao, X., Liu, J., Zhu, Y., Dai, Q., Wang, C., Lin, K., & Jiang, L. (2024). Early‐Responsive Immunoregulation Therapy Improved Microenvironment for Bone Regeneration Via Engineered Extracellular Vesicles. Advanced Healthcare Materials, 13(11). https://doi.org/10.1002/adhm.202303681

Vancouver

Lu T, Liu Y, Huang X, Sun S, Xu H, Jin A, et al. Early‐Responsive Immunoregulation Therapy Improved Microenvironment for Bone Regeneration Via Engineered Extracellular Vesicles. Advanced Healthcare Materials. 2024;13(11). doi:10.1002/adhm.202303681

BibTeX
@article{Lu2024,
  author = {Lu, Tingwei and Liu, Yuanqi and Huang, Xiangru and Sun, Siyuan and Xu, Hongyuan and Jin, Anting and Wang, Xinyu and Gao, Xin and Liu, Jingyi and Zhu, Yanfei and Dai, Qinggang and Wang, Chao and Lin, Kaili and Jiang, Lingyong},
  title = {Early‐Responsive Immunoregulation Therapy Improved Microenvironment for Bone Regeneration Via Engineered Extracellular Vesicles},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {11},
  doi = {10.1002/adhm.202303681}
}
Kostenlos starten →